HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabio Del Bello Selected Research

1,4-dioxane (dioxane)

4/2019Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells.
4/2019Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.
1/2019Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabio Del Bello Research Topics

Disease

6Neoplasms (Cancer)
03/2022 - 11/2014
4Pain (Aches)
09/2017 - 11/2009
3Bulimia (Binge Eating)
10/2021 - 01/2019
2Feeding and Eating Disorders (Eating Disorder)
10/2021 - 07/2020
2Neuralgia (Stump Neuralgia)
01/2020 - 09/2017
2Prostatic Neoplasms (Prostate Cancer)
04/2019 - 12/2014
2Breast Neoplasms (Breast Cancer)
04/2019 - 02/2010
2Parkinson Disease (Parkinson's Disease)
01/2019 - 01/2019
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
08/2015 - 07/2012
2Morphine Dependence
07/2012 - 11/2010
1Central Nervous System Diseases (CNS Diseases)
10/2021
1Body Weight (Weight, Body)
10/2021
1Obesity
10/2021
1Bone Resorption
01/2021
1Communicable Diseases (Infectious Diseases)
12/2020
1Hyperphagia (Overeating)
10/2020
1Substance-Related Disorders (Drug Abuse)
07/2020
1Chronic Pain
08/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Dyskinesias (Dyskinesia)
01/2019
1Chronic Disease (Chronic Diseases)
12/2015
1Xerostomia
08/2014
1Opioid-Related Disorders (Opiate Addiction)
09/2013
1Depressive Disorder (Melancholia)
09/2013
1Salter-Harris Fractures
02/2013

Drug/Important Bio-Agent (IBA)

55-HT1A Serotonin ReceptorIBA
04/2019 - 07/2012
5Morphine (MS Contin)FDA LinkGeneric
12/2015 - 11/2009
4LigandsIBA
10/2021 - 09/2017
3ImidazolinesIBA
01/2020 - 12/2015
31,4-dioxane (dioxane)IBA
04/2019 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
03/2022 - 04/2020
2CateninsIBA
01/2021 - 02/2013
2Biological ProductsIBA
10/2020 - 04/2019
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2020 - 04/2019
2N-Methylaspartate (NMDA)IBA
04/2020 - 04/2019
2Pharmaceutical PreparationsIBA
01/2019 - 11/2014
2Adrenergic Receptors (Adrenergic Receptor)IBA
09/2017 - 08/2015
2Opioid Analgesics (Opioids)IBA
12/2015 - 01/2012
2Antidepressive Agents (Antidepressants)IBA
08/2015 - 07/2012
22- (1- (2- allylphenoxy)ethyl)- 4,5- dihydro- 1H- imidazoleIBA
08/2015 - 07/2012
1Dopamine D3 ReceptorsIBA
10/2021
1EnzymesIBA
10/2021
1AcyltransferasesIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1Hormones (Hormone)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
10/2021
1Peptide Hormones (Polypeptide Hormones)IBA
10/2021
1GhrelinIBA
10/2021
1MetalsIBA
12/2020
1ZincIBA
12/2020
1Trace Elements (Biometals)IBA
12/2020
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
07/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1Formaldehyde (Formol)FDA Link
08/2019
1Antineoplastic Agents (Antineoplastics)IBA
04/2019
1spipethianeIBA
01/2019
1Levodopa (L Dopa)FDA LinkGeneric
01/2019
1Gabapentin (Neurontin)FDA LinkGeneric
09/2017
1Yohimbine (Yocon)IBA
09/2017
1N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
09/2017
1Hypnotics and Sedatives (Sedatives)IBA
08/2015
1CalciumIBA
12/2014
1Ion Channels (Ion Channel)IBA
12/2014
1Phosphotransferases (Kinase)IBA
11/2014
1NucleosidesIBA
11/2014
1cevimeline (Evoxac)FDA Link
08/2014
1Opiate AlkaloidsIBA
09/2013
1Naloxone (Narcan)FDA LinkGeneric
07/2012
1Cytostatic AgentsIBA
02/2010
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2009

Therapy/Procedure

4Analgesia
08/2015 - 11/2009
2Therapeutics
01/2020 - 01/2019
1Drug Therapy (Chemotherapy)
01/2021
1Oral Administration
01/2020